Navigation Links
Brain Tumor Drug in Frogs A New Report

is needed. It will have no effect on other cells because it is only capable of recognising and binding to the sugar coating of tumour cells.

Amphinase is in the very early stages of development, so it is likely to be several years and many trials before it could be developed into a treatment for patients, said Professor Acharya and his colleagues Drs Umesh Singh and Daniel Holloway.

Having said that, the early data is promising and through this study we have provided the kind of information needed if approval for use is requested in the future.Amphinase is the second anti-tumour ribonuclease to be isolated by Alfacell Corporation from Rana pipiens oocytes.

The other, ONCONASE(R) (ranpirnase), is currently in late-stage clinical trials as a treatment for unresectable malignant mesothelioma, a rare and fatal form of lung cancer, and in Phase I/II clinical trials in non-small cell lung cancer and other solid tumours.

We are pleased with the superb work performed by Professor Acharya and his talented team at the University of Bath, commented Kuslima Shogen, Alfacells chairman and chief executive officer.

Their work is critical to the continued development and understanding of our family of novel ribonuclease based therapeutics with the potential to help patients suffering from cancer and other dismal diseases.The company is now working on pre-clinical trials of Amphinase with a view to beginning clinical trials in the future.


'"/>




Page: 1 2

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Brain death – How to cope with it
3. “Brain fingerprinting”- The new lie detectr
4. Nasal Spray Could Take Drugs Direct to Brain.
5. Virus Combats Brain Tumour
6. Nasal Spray Could Take Drugs Directly to Brain
7. Control of anger disorder connected to Brain Dysfunction
8. High Levels of Protein Linked to Brain Shrinkage
9. Brain damage affects artistic skill
10. Brain cells protected by new compounds
11. Brain changes observed in people with sleep apnoea
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Brain Tumor Drug Frogs New Report

(Date:12/5/2008)... Dr. Alan Greene from the kids, health website DrG...y organic food. It,s the same benchmark that lives... Danville, CA (PRWEB) Decembe...organic by the Department of Agriculture in three ...ne, why not people?, , , , ,In an article this we...
(Date:12/4/2008)...re-FirstCall/ -- Cell Therapeutics, Inc. ("CTI",o...unced that that its Board,of Directors has author...urchase a portion or all of five series of Convert...- 4% Convertible Senior Subordinated Notes due 201..., -- 6.75% Convertible Senior Notes due 2010, ...
(Date:12/4/2008)... disease in cystic fibrosis (CF), combined with ag...ontrolling the progression of the disease, accordi...rary to previous scientific opinion, progressive l...fancy even though lung function shortly after diag...me of the lung function reduction we,re identifyin...
(Date:12/4/2008)...Newswire-USNewswire/ -- In the 1983 movie "A Chris...d that a Red Ryder BB gun is the perfect gift. , ...nse he got from his parents, teacher and even Sant...ble quotes from this Christmas classic because we,...nd unfortunately, it comes true for too many peopl...
Breaking Medicine News(10 mins):Health News:Dr. Alan Greene: The Organic Man -- Renowned Pediatrician Marks Third Anniversary of Organic-Only Diet 2Health News:Dr. Alan Greene: The Organic Man -- Renowned Pediatrician Marks Third Anniversary of Organic-Only Diet 3Health News:Cell Therapeutics, Inc. to Offer to Repurchase up to $124 Million of Its Notes 2Health News:Cell Therapeutics, Inc. to Offer to Repurchase up to $124 Million of Its Notes 3Health News:Intervention in infants with cystic fibrosis key to slowing progression 2Health News:Intervention in infants with cystic fibrosis key to slowing progression 3Health News:Texas Parents Can Prevent Holiday Tragedies with Safe Toys and Celebrations 2
...t enabled gay men contact in Hong Kong has been in...according to a latest report. // Government healt... 2003 and November 2005, had HIV with similar gene...a Morning Post reported. The discovery was made w...
...ted among Americans has revealed that most of them... to a mere chance. The results of the study may no...rns about sex selection may be prevalent, leading ...und that only eight percent of people would use pr...
...t three feet tall and 37 pound in weight prior to... baby is her first child. // Eloysa Vasquez, conf...is imperfecta , a disorder that has rendered her b... had two miscarriages as well. During the pregnan...
...a mental health court, the first one of its kind i... motive to pick // out sober and non violent defen... them to languish in the jails. U.S. House Speake...,000 fund to help with administration of Kane Coun...
Other Medicine News:Health News:Americans Not Interested In Choosing Sex Of Child: Survey 2
(Date:12/3/2008).... Jude treatment alleviates long-term anemia and o...plications , , MEMPHIS, Tenn., Dec. 3 /PRN...nsert a corrective gene into mouse blood cells, sc...have alleviated sickle cell disease pathology. In ...ted mice showed essentially no difference from nor...
(Date:12/3/2008)..., Del., Dec. 3 Isogen, a contract ...erile filling, announced it has retained a,strate... to meet the global,biopharma demand for Isogen,s...d a successful first round series of capital,inve...acility in Q1 2009 to,deliver on the previously u...
(Date:12/3/2008)...EGO, Dec. 3 Vical Incorp...sive, binding letter of intent with EIP,Eczacibas...g of the company,s,Allovectin-7(R) immunotherapeu...epublic of Northern Cyprus. EIP has agreed to obta...ritory and to pay Vical upfront and milestone paym...
(Date:12/2/2008)...DGE, Mass., Dec. 2 Biopu...that the U.S. Naval Medical Research Center,(NMRC...n (FDA) a revised,investigational new drug (IND) ...mpany,s oxygen therapeutic Hemopure(R) [hemoglobin...ttlefield treatment of trauma patients. The study ...
Breaking Medicine Technology:Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 2Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 3Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 2Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 2Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 4Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 5U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 2U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 3Sage Software Healthcare Inc Announces Intergy by Sage and Intergy EHR by Sage installations for 2007 7649 1Sage Software Healthcare Inc Announces Intergy by Sage and Intergy EHR by Sage installations for 2007 7649 2Infant Development Program from EASY Baby Takes On the Sixty Percent Increase in Developmental Delays in Children 7647 1Infant Development Program from EASY Baby Takes On the Sixty Percent Increase in Developmental Delays in Children 7647 2Advances in Blood Cancer Therapy to be Highlighted at American Society of Hematology Conference 7645 1Advances in Blood Cancer Therapy to be Highlighted at American Society of Hematology Conference 7645 2Advances in Blood Cancer Therapy to be Highlighted at American Society of Hematology Conference 7645 3Teen Birth Rates Up for First Time in 14 Years U S Reports 7643 1Teen Birth Rates Up for First Time in 14 Years U S Reports 7643 2Teen Birth Rates Up for First Time in 14 Years U S Reports 7643 3
...PARK, Calif.--(BUSINESS WIRE)--Jun 11, 2007 - Gero...esentation of,research studies indicating that GRN...C)-based therapeutic for the treatment of,spinal c...mune,system., Presented by Geron scientist Ross Ok...ieties meeting in San Diego, the findings,could me...
...he Netherlands, June 11, 2007-Sugammadex - the nov...eveloped by Organon,the human healthcare business...pivotal trial a 9-12 times faster reversal of,neur...hout evidence,of post operative residual curarizat..., 2 The results of this pivotal Aurora trial,were ...
Other Medicine Technology:Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 2Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 3Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial Compared to Neostigmine 2Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial Compared to Neostigmine 3
...ne-125 implant is a combination of innovative desi...e visibility that makes BrachySource I-125 implant...You can be confident that every BrachySource I-125...rvices which is required by clinicians who must me...
...ne-125 implant is a combination of innovative desi...e visibility that makes BrachySource I-125 implant...You can be confident that every BrachySource I-125...rvices which is required by clinicians who must me...
The Double-J Closed Tip Ureteral Stent design revolutionized stenting over 15 years ago. Today, it remains one of the most widely used stents in the world. An exclusive ACMI design allows one-step in
...ternal drainage from the ureteropelvic junction to...e segment with no sideports prevents postoperative...ingrowth of the ureteral wall to the stent. Suppli...-time use. CAUTION: Periodic evaluation is advised...
Medicine Products: